Collaborative Care

04/22/2014 - 11:48am

NBTY, a global manufacturer and distributor or vitamins and nutritional supplements, introduced Nature's Origin, the company's first complete line of vitamins, minerals and herbal supplements.

04/22/2014 - 10:05am

CVS Caremark’s MinuteClinic has surpassed 20 million patient visits since opening the nation's first store-based clinic in 2000, the company has announced.

04/22/2014 - 8:29am

Novartis on Tuesday made a number of moves that have fundamentally reshaped its business, according to published reports.

04/22/2014 - 7:20am

The Pharmacy Technician Certification Board announced that Certified Pharmacy Technicians eligible to recertify are now required to complete one hour of continuing education in patient safety, in addition to the already required hour of law CE, as part of 20 hours of CE needed for recertification.

04/22/2014 - 7:11am

Eli Lilly on Monday announced that the Food and Drug Administration has approved Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

04/21/2014 - 1:48pm

Walgreens on Monday announced that it is now offering expanded travel health services, including immunizations and consultations, to support the nearly 60 million annual planned trips by U.S. residents venturing outside the country.

04/21/2014 - 11:51am

GlaxoSmithKline and Genmab A/S announced last week that the Food and Drug Administration has approved a supplemental biologic license application for the use of Arzerra (ofatumumab) in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia for whom fludarabine-based therapy is considered inappropriate.

04/21/2014 - 8:51am

Mylan on Friday announced that Supreme Court Chief Justice John Roberts has denied Teva's application for an injunction seeking to prevent Mylan's launch of a generic version of Copaxone (glatiramer acetate injection) pending the Supreme Court's decision on Teva's appeal.

04/18/2014 - 11:27am

A new study in the American Journal of Preventive Medicine analyzing weekly patterns in health-related Google searches reveals a recurring pattern that could be leveraged to improve public health strategies.

04/18/2014 - 11:10am

Actavis and Forest Laboratories on Thursday announced that they have each received a request for additional information from the Federal Trade Commission in connection with Actavis' pending acquisition of Forest.